Chemoinformaics analysis of 6-HydroxyLuteolin
| Molecular Weight | 302.238 | nRot | 1 |
| Heavy Atom Molecular Weight | 292.158 | nRig | 18 |
| Exact Molecular Weight | 302.043 | nRing | 3 |
| Solubility: LogS | -3.521 | nHRing | 1 |
| Solubility: LogP | 2.33 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 37.3319 |
| nHD | 5 | BPOL | 12.6361 |
| QED | 0.434 |
| Synth | 2.556 |
| Natural Product Likeliness | 1.522 |
| NR-PPAR-gamma | 0.965 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.089 |
| HIA | 0.165 |
| CACO-2 | -5.203 |
| MDCK | 0.00000786 |
| BBB | 0.002 |
| PPB | 0.951488 |
| VDSS | 0.575 |
| FU | 0.0993751 |
| CYP1A2-inh | 0.935 |
| CYP1A2-sub | 0.13 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.045 |
| CYP2c9-inh | 0.552 |
| CYP2c9-sub | 0.368 |
| CYP2d6-inh | 0.14 |
| CYP2d6-sub | 0.202 |
| CYP3a4-inh | 0.118 |
| CYP3a4-sub | 0.048 |
| CL | 7.368 |
| T12 | 0.922 |
| hERG | 0.076 |
| Ames | 0.562 |
| ROA | 0.038 |
| SkinSen | 0.956 |
| Carcinogencity | 0.103 |
| EI | 0.934 |
| Respiratory | 0.129 |
| NR-Aromatase | 0.898 |
| Antiviral | Yes |
| Prediction | 0.73543 |